Integer Holdings Corporation ITGR 深 沪
已收盘 01-30 16:00:00 美东时间
86.86
+0.390
+0.45%
华盛通- 最 高87.39
- 今 开86.67
- 成交量 72.01万股
- 最 低 85.49
- 昨 收 86.47
- 总市值 30.43亿
- 52周最高 144.76
- 市盈率 静 25.65
- 换手率 2.06%
- 52周最低 62.00
- 委 比 50.00%
- 总股本 3503.84万
- 历史最高 146.36
- 量 比 1.58
- 振 幅 2.20%
- 历史最低 15.2167
- 每 手 1
- 风险率 20.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Integer Holdings Showcases Expanded R&D Solutions at MD&M West 2026
Integer Holdings Showcases Expanded R&D Solutions at MD&M West 2026 Integer Holdings Corp., a leading global medical device contract development and manufacturing organization, will exhibit at MD&M West 2026 in Anaheim, California, from February 3 to 5. The company will unveil a new, expanded booth
01-28 21:00
Integer Announces Conference Call to Discuss Fourth Quarter and Full Year 2025 Results
Integer Holdings Corporation (NYSE: ITGR) announced that it will hold a conference call on February 19, 2026, at 8 a.m. CT / 9 a.m. ET to discuss its Q4 and full-year 2025 financial results and business highlights. A live webcast with registration is available. Participants can join via phone using (800) 715-9871 (US) or (646) 307-1963 (int'l) with Conference ID 3120125. An audio replay will be available for seven days. More details at investor.i...
01-22 13:00
Investors Sue Integer (ITGR) Over Heart Device Claims
A class action lawsuit was filed against Integer Holdings Corporation ($ITGR) o...
01-20 01:29
Integer to Showcase Innovations in Neuromodulation, Miniaturized Active Implantable Device Technology During NANS 2026 Annual Meeting
Integer Holdings Corporation, a leading medical device CDMO, will exhibit at the NANS Annual Meeting in Las Vegas (Jan. 22–25). At booth #115, they will showcase advancements in neuromodulation and miniaturized active implantable devices, aiming to accelerate development and reduce risks for medical device companies. Their Xcellion® Gen 3 battery technology offers fast charging and exceptional runtime. Visit [www.integer.net](https://www.integer....
01-14 13:00
2026年展望 | 不止脑机接口！AI巨头开辟医疗“新战场”，这些相关标的值得提前了解
不止脑机接口！AI巨头扎堆布局医疗赛道，技术突破+需求爆发双轮驱动！这22家潜力公司名单抢先看，阿里健康开年已暴涨50%>>
01-14 11:52
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
'Activist Irenic Pushing Medical-Device Maker Integer to Pursue Sale'- WSJ
https://www.wsj.com/business/deals/activist-irenic-pushing-medical-device-maker-integer-to-pursue-sale-0a1b3fd4
2025-12-18 06:10
美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
2025-12-12 10:24
Citigroup Maintains Neutral on Integer Holdings, Raises Price Target to $75
Citigroup analyst Joanne Wuensch maintains Integer Holdings (NYSE:ITGR) with a Neutral and raises the price target from $69 to $75.
2025-12-12 05:03
美股大行评级 | 摩根大通上调百度至"超配"，目标价升至188美元！Navan获多家机构首予"买入"评级，目标价最高30美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从4美元升至9美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从32美元升至38美元
2025-11-25 10:27
